ANGLE Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
ANGLE Stock Forecast and Price Target
Given the average yearlong price target of £0.69 provided by prominent analysts over the past few months, there is a potential upside of approximately 360% from the last closing price in April, 2024 for ANGLE's stock if it is reached. This estimation is based on a high estimate of £0.70 and a low estimate of £0.67. If you're looking for information on ANGLE stock, consider checking out the forecasts for comparable firms such as NasdaqGS:ILMN.
360.00% Upside
ANGLE Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, ANGLE's Price has grown, increasing from £0.00 to £0.00 – a growth of 100.00%. The next year looks promising for ANGLE, with analysts predicting Fair Value of £0.16 – an increase of 100.00%. Over the next seven years, experts anticipate that ANGLE's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$573.60 | Buy/Sell | $591.94 | 7.22% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF221.00 | Buy/Sell | CHF307.83 | 23.30% |
| ILMN Stock Forecast | Illumina | Outperform |
16
|
$122.28 | Buy/Sell | $159.28 | 22.67% |
| 6869 Stock Forecast | Sysmex | Outperform |
18
|
¥7.99k | Buy/Sell | ¥8.90k | 11.40% |
| NTRA Stock Forecast | Natera | Outperform |
7
|
$91.66 | Buy/Sell | $74.41 | 12.37% |
ANGLE Revenue Forecast for 2023 - 2025 - 2030
In the last two years, ANGLE's Revenue has grown, increasing from £760.00k to £1.04M – a growth of 36.84%. The next year looks promising for ANGLE, with analysts predicting Revenue of £9.25M – an increase of 789.42%. Over the next seven years, experts anticipate that ANGLE's Revenue will grow at a rate of 20476.92%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$41.65 | Buy/Sell | $0.00 | 20.05% |
| GH Stock Forecast | Guardant Health | Buy |
6
|
$17.35 | Buy/Sell | $43.00 | 153.60% |
| NEO Stock Forecast | NeoGenomics | Outperform |
8
|
$14.14 | Buy/Sell | $20.09 | 41.44% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATOS Stock Forecast | Atossa Genetics Inc | Buy |
5
|
$1.53 | Buy/Sell | $4.83 | 161.44% |
| 8YY Stock Forecast | Biolidics | - |
-13
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| NVTA Stock Forecast | Invitae | - |
4
|
$0.00 | Buy/Sell | $0.71 | 0.00% |
ANGLE EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, ANGLE's EBITDA has grown by 100.68%, rising from £-11.76M to £-23.60M. In the following year, 2 experts forecast ANGLE's EBITDA will decrease by 30.93%, to £-16.30M. In 2030, professionals predict that ANGLE's EBITDA will decrease by 451.69%, to £83.00M.
ANGLE EBIT Forecast for 2023 - 2025 - 2030
In the last two years, ANGLE's EBIT has grown by 95.72%, rising from £-12.62M to £-24.70M. According to 2 major analysts, ANGLE's EBIT will fall by 20.45% in the next year, reaching £-19.65M. Professionals believe that By 2030, ANGLE's EBIT will fall to £61.00M– a 346.96% decrease from its current value.
ANGLE EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, ANGLE's EPS has grown, increasing from £-0.07 to £0.00 – a growth of 100.00%. The next year looks promising for ANGLE, with analysts predicting EPS of £-0.07 – an increase of 100.00%. Over the next seven years, experts anticipate that ANGLE's EPS will grow at a rate of 100.00%.
.jpg)